PARP-ARPI Combo Sets New Standard for Metastatic Hormone-Sensitive Prostate Cancer

(MedPage Today)-Chicago-Men with HRR repairs (HRR)-urgent, metola, and prostate cancer sensitive (MCSPC) has lived significantly longer without the development of the disease when they received PARP in addition to …